Mpm Bioventures 2018 L.p. insider trades

Open-market stock purchases and sales by Mpm Bioventures 2018 L.p., Unknown at Aktis Oncology, Inc, from SEC Form 4 filings since Sep 21, 2020.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -29%.

Recent trades

DateStockTradeValue
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought$20M
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—
Jan 12, 2026AKTS Aktis Oncology, IncBought (not open market)—

Companies traded

  • AKTS Aktis Oncology, Inc: 1 buy, last Jan 12, 2026
  • ITOS iTeos Therapeutics, Inc: 73 sales, last May 13, 2025
  • TRDA Entrada Therapeutics, Inc: 1 buy, 2 sales, last Dec 11, 2024
  • DYN Dyne Therapeutics, Inc: other filings, last Sep 21, 2020

Get free alerts when Mpm Bioventures 2018 L.p. files a new trade →